Pharmaceuticals Industry

Pharmaceutical industry is boon to any country for its commitment towards alleviation of chronic/non-chronic disease by new chemical entity or generics. To facilitate this objective, an organization faces many IP and technology challenges for bringing new innovative drug in market or launching generics at reasonable prices to mass.

Providing solutions for IP and technology challenges pertaining at any stage of R&D/launch of novel molecules and generics does require very extensive knowledge of the subject matter apart from expertise in executing various IP & technology intelligence projects. IEBS pharma team fits exactly in this context. The team comprises of people having an impeccable blend of subject knowledge, industry R&D and IP experience.

IEBS pharma team has provided innovative IP and technology solutions to pharmaceutical companies worldwide in various domains – small molecules, biotherapeutics, biosimilars, therapies for rare diseases, secondary indications etc.

Subject Matter Expertise

Significant Breadth and Depth Experience Across the Pharmaceuticals Domain

  • Peptide Therapy
  • Vaccines
  • Implants
  • Regenerative Medicine
  • Alternative Medicine
  • Modified Drug Delivery
  • Targeted Drug Delivery
  • Nano Drug Delivery
  • Local Drug Delivery
  • Pharmacogenomics
  • Pharmacology
  • Nano-drugs
  • Formulation
  • Small Molecules
  • Drug Synthesis/Process

Case Studies

Past Projects

Technology Intelligence

  • Technology Drug formulation with increased bioavailability for dosage reduction
  • Technology Landscape PEG-conjugated small molecules
  • Innovation Small molecule drug targets in cancer
  • Technology Intelligence Solid phase peptide synthesis in therapeutics
  • White Space Analysis Epigenetics in cancer therapeutics
  • Technology Landscape Antibody Drug conjugate in cancer therapeutics

IP Intelligence

  • Patent Landscape on Stem cell cellular disease models
  • Freedom on Small molecule metabolite as glucose biosensor
  • Freedom on Microbubble DNA and RNA Delivery Technology
  • Patentability on Humanized TTR Mice
  • Prior on Octreolide Delivery
  • Patent Landscape on Epidermal growth factor receptor (EGFR) kinase inhibitors in cancer therapeutics

Business Intelligence

  • Market Assessment on Organic Excipients
  • Competitive Intelligence on Oral mouth rinse for kids
  • Business Opportunities Non invasive drug delivery system
  • Market size Monoclonal Antibodies
  • Market Opportunity Assesment Existing and Potential market of Crispr/cas9

Request Sample

Name*:

Phone No.*:

Email*:

Service Intersted In:

Client Speak

“Ingenious has really come up with the unexpected results in project and within the time deadlines”
Director-IP, Novartis

Download Sample

Technology Intelligence
IP Intelligence
Business Intelligence